within Pharmacolibrary.Drugs.D_Dermatologicals.D08A_AntisepticsAndDisinfectants.D08AH30_Clioquinol;

model Clioquinol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.3,
    Cl = 8.333333333333333e-07,
    adminDuration = 600,
    adminMass = 250 / 1000000,
    adminCount = 1,
    Vd = 0.0015,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.0008333333333333334,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Clioquinol</td></tr><tr><td>ATC code:</td><td>D08AH30</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>250</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.5</td><td>L</td></tr>
    <tr><td>clearance:</td><td>3</td><td>L/hr</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Clioquinol (ATC code D08AH30) is an antifungal and antibacterial agent, historically used topically to treat skin infections and sometimes intestinal amebiasis or diarrhea. Its oral use has been discontinued in many countries due to neurotoxicity risk. Topical formulations are still available in some regions.</p><h4>Pharmacokinetics</h4><p>No robust pharmacokinetic data in humans available; parameters below are estimates based on physicochemical properties and sparse animal data.</p><h4>References</h4><ol><li><p>Schimmer, AD, et al., &amp; Minden, MD (2012). A phase I study of the metal ionophore clioquinol in patients with advanced hematologic malignancies. <i>Clinical lymphoma, myeloma &amp; leukemia</i> 12(5) 330–336. DOI:<a href=\"https://doi.org/10.1016/j.clml.2012.05.005\">10.1016/j.clml.2012.05.005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22683301/\">https://pubmed.ncbi.nlm.nih.gov/22683301</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.D.D08AH30 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Clioquinol;
